Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$29.7M
+202.2% from 2023
Prescriptions
1,112
$26,664.36 per claim
Patients
228
154 prescribers
Total spending, 2024
$29.7M
$130,047.21 per patient
Medicare prescription drug plans paid $29.7M for Recorlev in 2024, for 1,112 prescriptions and refills to 228 patients (up 202.2% from 2023). The average cost per claim was $26,664.36.
Texas had the highest Medicare cost for Recorlev in 2024: $3.3M for 129 claims, followed by Georgia ($3.3M).
Hansel M Rayner, internal medicine in McDonough, GA, had the highest Medicare cost for Recorlev in 2024: 79 claims costing $2.4M.
Recorlev is made by Xeris Biopharma Holdings, Inc. (XERS), listed in the Medicare spending data as Xeris Pharmaceu.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Hansel M Rayner McDonough, GA | Internal Medicine | 79 | 17 | $2.4M |
| Lee N Metchick Deland, FL | Endocrinology | 38 | Under 11 | $1.0M |
| Jawaad S Khokhar |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 30 | 122 | 35 | $2.4M |
| 2023 | 75 | 384 | 85 | $9.8M |
| 2024 | 154 | 1,112 | 228 | $29.7M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 19 |
| Under 11 |
| $809K |
| Miriam H Ahmad Falls Church, VA | Internal Medicine | 12 | Under 11 | $806K |
| Christopher P Lucci Rockport, TX | General Practice | 21 | Under 11 | $763K |
| Benjamin D Prohaska Reno, NV | Physician Assistant | 34 | Under 11 | $750K |
| Lauren Hendricks Raleigh, NC | Nurse Practitioner | 12 | Under 11 | $749K |
| Geraldo A Saavedra Whitehall, PA | Endocrinology | 12 | Under 11 | $694K |
| Elena A Christofides Columbus, OH | Endocrinology | 33 | Under 11 | $606K |
| Kevin C Yuen Phoenix, AZ | Endocrinology | 22 | Under 11 | $556K |
| Ronald S Watts Stockbridge, GA | Endocrinology | 28 | Under 11 | $520K |
| Benjamin B Brannick Memphis, TN | Endocrinology | 13 | Under 11 | $520K |
| Beatriz R Esayag-Tendler Farmington, CT | Endocrinology | 11 | Under 11 | $485K |
| Firas Akhrass San Antonio, TX | Endocrinology | 21 | Under 11 | $471K |
| Keren Zhou Cleveland, OH | Endocrinology | 13 | Under 11 | $469K |
| Suzi Kochar Goodyear, AZ | Endocrinology | 19 | Under 11 | $453K |
| Julie M Talavera Metairie, LA | Endocrinology | 12 | Under 11 | $427K |
| Lisa M Gavosto Tampa, FL | Nurse Practitioner | 12 | Under 11 | $398K |
| Sabreen Ahmed Greenbelt, MD | Internal Medicine | 11 | Under 11 | $381K |
| Brian C Jameson Wilkes Barre, PA | Endocrinology | 12 | Under 11 | $378K |
| Brooke S McAdams Columbia, SC | Endocrinology | 11 | Under 11 | $364K |
| Kent J Lyon Athens, GA | Endocrinology | 11 | Under 11 | $364K |
| Ashkan M Zand Pasadena, TX | Endocrinology | 15 | Under 11 | $364K |
| Ameya Hodarkar Burlington, MA | Endocrinology | 13 | Under 11 | $357K |
| Lance A Sloan Lufkin, TX | Endocrinology | 12 | Under 11 | $339K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Xeris Pharmaceu XERS | 1,112 | $29.7M |